BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung
,
Avian flu virus
,
Rosiglitazone
,
rs2476601
,
KLK3
,
Response to oxidative stress
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
3- o- methyldopa
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Streamlined determination of 3-O-methyldopa in dried blood spots: Prospective screening for aromatic…
Evaluation of 3-O-methyldopa as a biomarker for aromatic L-amino acid decarboxylase deficiency in 7 …
Simultaneous determination of 5-hydroxytryptophan and 3-O-methyldopa in dried blood spot by UPLC-MS/…
Detection of 3-O-methyldopa in dried blood spots for neonatal diagnosis of aromatic L-amino-acid dec…
Effect of Opicapone Tablets on Levodopa and 3-O-Methyldopa Pharmacokinetics in Healthy Japanese Subj…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Bioequivalence Study on Two Methyldopa Tablet 250mg Formulations
A Comparison of Compliance Between Clonidine Patch and Methyldopa for the Treatment of Chronic Hyper…
Prevalence of High Plasmatic 3OMethyldopa Level in a Specific Population of Patients With a Symptoma…
Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide
A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ